By Michael Kim NASDAQ:BENF READ THE FULL BENF RESEARCH REPORT After the market closed on 11/14/24, Beneficient (NASDAQ:BENF) reported F2Q25 (Sep) earnings results. On a GAAP basis, BENF reported net income of $0.03 per Class A diluted share for F2Q25 – the company’s second consecutive profitable quarter as a public company – versus a loss … Read more
By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more
By M. Marin NYSE:AMS READ THE FULL AMS RESEARCH REPORT Full quarter consolidation Rhode Island, some contribution from Puebla, anticipate 6.7% Q/Q 3Q24 revenue increase American Shared Hospital Services’ (NYSE:AMS) will report 3Q24 results on November 13, 2024, and hold a conference call that day at 1:00 pm ET. The company provides stereotactic radiosurgery equipment … Read more
By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported third quarter results on November 6th, 2024. Revenues totaled $8.2 million and the burn trial has completed enrollment while the emergency department burn enrollment continues. The company also received additional funding from the Medical Technology Enterprise Consortium (MTEC) to … Read more
By Lisa Thompson NYSE:MHH READ THE FULL MHH RESEARCH REPORT After seven quarters of declining year-over-year revenues, Mastech (NYSE:MHH) reported revenue growth of 8.5% in Q3 2024. Gross margin was again at an all-time high, and income is growing faster than revenues. As a result, we are raising our Q4 2024 and 2025 EPS estimates … Read more
